Global AI Medical Imaging Product Market Growth (Status and Outlook) 2026-2032
Description
The global AI Medical Imaging Product market size is predicted to grow from US$ 1108 million in 2025 to US$ 5985 million in 2032; it is expected to grow at a CAGR of 27.3% from 2026 to 2032.
AI Medical Imaging Products refer to software-centric medical technologies that apply artificial intelligence algorithms—primarily deep learning and computer vision—to the acquisition, processing, interpretation, and management of medical images. These products analyze imaging data generated from modalities such as X-ray, CT, MRI, ultrasound, and nuclear imaging (PET/SPECT) to support clinical decision-making. Core functions include automated lesion detection, disease classification, image segmentation, quantitative measurement, workflow triage, and prognosis prediction. Unlike traditional CAD systems, modern AI medical imaging products are data-driven, continuously trainable, and increasingly integrated into hospital PACS/RIS systems or embedded directly into imaging equipment. They are widely used across high-burden disease areas such as oncology, cardiovascular disease, neurology, and pulmonary disorders, addressing challenges including diagnostic variability, clinician workload, and imaging data overload. From a commercial perspective, these products are delivered through standalone software, cloud-based platforms, or embedded solutions, with monetization models ranging from perpetual licenses to subscription and per-scan fees.
AI Medical Imaging Products can be classified by imaging modality (X-ray, CT, MRI, ultrasound), clinical function (detection, diagnosis, segmentation, workflow optimization), disease focus (oncology, cardiology, neurology), deployment model (on-premise, cloud-based, hybrid), and product form (standalone software, SDK/module, or integrated system). Key parameters include algorithm accuracy (AUC, sensitivity, specificity), inference speed, data compatibility, regulatory clearance status, and integration capability with existing IT systems.
Upstream participants include imaging equipment manufacturers, medical data providers, cloud infrastructure vendors, and AI algorithm developers. Midstream players are AI medical imaging software companies responsible for model development, validation, and regulatory approval. Downstream customers include hospitals, diagnostic imaging centers, and increasingly tele-radiology and healthcare platform providers.
AI Medical Imaging Products typically exhibit high gross margins (70–85%), driven by software-centric cost structures and scalable deployment. Market growth is fueled by rising imaging volumes, radiologist shortages, regulatory approvals in major markets, and the shift toward value-based healthcare. Future trends include deeper workflow integration, multi-modal AI models, cloud-native deployment, and expansion into emerging markets.
LPI (LP Information)' newest research report, the “AI Medical Imaging Product Industry Forecast” looks at past sales and reviews total world AI Medical Imaging Product sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Medical Imaging Product sales for 2026 through 2032. With AI Medical Imaging Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Medical Imaging Product industry.
This Insight Report provides a comprehensive analysis of the global AI Medical Imaging Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Medical Imaging Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Medical Imaging Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Medical Imaging Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Medical Imaging Product.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Medical Imaging Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
Standalone AI Imaging Software
AI Imaging Modules / SDKs
AI-enabled Imaging Systems (Software + Hardware)
Subscription-based AI Platforms (SaaS)
Per-scan / Usage-based AI Services
Segmentation by Imaging Modality:
AI for X-ray Imaging
AI for CT Imaging
AI for MRI Imaging
AI for Ultrasound Imaging
AI for Nuclear Medicine Imaging（PET / SPECT）
Segmentation by Clinical Function:
AI-assisted Detection (CADe)
AI-assisted Diagnosis (CADx)
Segmentation & Quantification AI
Workflow & Triage AI
Prognosis & Treatment Response Prediction
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
AEYE Health
VUNO, Inc.
ScreenPoint Medical
Deepwise
INFERVISION
United Imaging
Shukun Technology
Keya Medical
YITU Healthcare
Beijing Huiyi Huiying
BioMind
Siemens Healthineers
GE HealthCare
Philips
Aidoc
Viz.ai
RapidAI
Subtle Medical
Lunit
Qure.ai
Nanox AI
Annalise.ai
HeartFlow
Cleerly
Please note: The report will take approximately 2 business days to prepare and deliver.
AI Medical Imaging Products refer to software-centric medical technologies that apply artificial intelligence algorithms—primarily deep learning and computer vision—to the acquisition, processing, interpretation, and management of medical images. These products analyze imaging data generated from modalities such as X-ray, CT, MRI, ultrasound, and nuclear imaging (PET/SPECT) to support clinical decision-making. Core functions include automated lesion detection, disease classification, image segmentation, quantitative measurement, workflow triage, and prognosis prediction. Unlike traditional CAD systems, modern AI medical imaging products are data-driven, continuously trainable, and increasingly integrated into hospital PACS/RIS systems or embedded directly into imaging equipment. They are widely used across high-burden disease areas such as oncology, cardiovascular disease, neurology, and pulmonary disorders, addressing challenges including diagnostic variability, clinician workload, and imaging data overload. From a commercial perspective, these products are delivered through standalone software, cloud-based platforms, or embedded solutions, with monetization models ranging from perpetual licenses to subscription and per-scan fees.
AI Medical Imaging Products can be classified by imaging modality (X-ray, CT, MRI, ultrasound), clinical function (detection, diagnosis, segmentation, workflow optimization), disease focus (oncology, cardiology, neurology), deployment model (on-premise, cloud-based, hybrid), and product form (standalone software, SDK/module, or integrated system). Key parameters include algorithm accuracy (AUC, sensitivity, specificity), inference speed, data compatibility, regulatory clearance status, and integration capability with existing IT systems.
Upstream participants include imaging equipment manufacturers, medical data providers, cloud infrastructure vendors, and AI algorithm developers. Midstream players are AI medical imaging software companies responsible for model development, validation, and regulatory approval. Downstream customers include hospitals, diagnostic imaging centers, and increasingly tele-radiology and healthcare platform providers.
AI Medical Imaging Products typically exhibit high gross margins (70–85%), driven by software-centric cost structures and scalable deployment. Market growth is fueled by rising imaging volumes, radiologist shortages, regulatory approvals in major markets, and the shift toward value-based healthcare. Future trends include deeper workflow integration, multi-modal AI models, cloud-native deployment, and expansion into emerging markets.
LPI (LP Information)' newest research report, the “AI Medical Imaging Product Industry Forecast” looks at past sales and reviews total world AI Medical Imaging Product sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Medical Imaging Product sales for 2026 through 2032. With AI Medical Imaging Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Medical Imaging Product industry.
This Insight Report provides a comprehensive analysis of the global AI Medical Imaging Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Medical Imaging Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Medical Imaging Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Medical Imaging Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Medical Imaging Product.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Medical Imaging Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
Standalone AI Imaging Software
AI Imaging Modules / SDKs
AI-enabled Imaging Systems (Software + Hardware)
Subscription-based AI Platforms (SaaS)
Per-scan / Usage-based AI Services
Segmentation by Imaging Modality:
AI for X-ray Imaging
AI for CT Imaging
AI for MRI Imaging
AI for Ultrasound Imaging
AI for Nuclear Medicine Imaging（PET / SPECT）
Segmentation by Clinical Function:
AI-assisted Detection (CADe)
AI-assisted Diagnosis (CADx)
Segmentation & Quantification AI
Workflow & Triage AI
Prognosis & Treatment Response Prediction
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
AEYE Health
VUNO, Inc.
ScreenPoint Medical
Deepwise
INFERVISION
United Imaging
Shukun Technology
Keya Medical
YITU Healthcare
Beijing Huiyi Huiying
BioMind
Siemens Healthineers
GE HealthCare
Philips
Aidoc
Viz.ai
RapidAI
Subtle Medical
Lunit
Qure.ai
Nanox AI
Annalise.ai
HeartFlow
Cleerly
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
178 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 AI Medical Imaging Product Market Size by Player
- 4 AI Medical Imaging Product by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global AI Medical Imaging Product Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
